Approaches to cervical cancer prevention and detection

The fourth most frequent malignancy in women globally is cervical cancer. Primary prevention and screening are the most effective ways to lower the cost of healthcare and deaths from cervical cancer. Most screening and diagnostic efforts in the United States and other developing nations are focused on early detection of high-risk human papillomavirus (HPV) lesions through HPV testing and pap smears. Members of the interprofessional team must understand that cervical cancer is a disease that somebody may avoid. If sexually active women have early human papillomavirus (HPV) immunization, it is mostly avoidable. The members of the interprofessional team and their patients cannot afford to pass up the chance to prevent cervical cancer with early HPV vaccination. The HPV vaccine has been accessible to prevent cervical cancer since 2006. Members of the interprofessional team have a moral responsibility to inform their young female patients about the chance to prevent cervical cancer. The members of the interprofessional team and their patients cannot afford to pass up the chance to prevent cervical cancer with early HPV vaccination. This activity discusses the diagnosis and treatment of cervical cancer. It emphasizes the need for the interprofessional team to give women of reproductive age the HPV vaccine to prevent the development of what is presently the fourth most prevalent cancer in females globally.